Selected research
Industry Growth & Trends
Global Nicorette Lozenges Industry Growth and Trends Forecast to 2032
Market perspective
The global Nicorette Lozenges market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nicorette Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nicorette Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nicorette Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nicorette Lozenges include Alchem International, Cambrex Corporation, Dr. Reddy's Laboratories, Fertin Pharma, Perrigo Company, Pharmacia, Revolymer, Reynolds American and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nicorette Lozenges market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nicorette Lozenges market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nicorette Lozenges market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nicorette Lozenges.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Nicorette Lozenges market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nicorette Lozenges Market by Company
Alchem International
Cambrex Corporation
Dr. Reddy's Laboratories
Fertin Pharma
Perrigo Company
Pharmacia
Revolymer
Reynolds American
GlaxoSmithKline
Novartis
Johnson & Johnson
Nicorette Lozenges Segment by Type
2 mg/piece Of Gum Dosage
4 mg/piece Of Gum Dosage
Nicorette Lozenges Segment by Application
Individual Smokers
Withdrawal Clinics
Medical Practice
Others
Nicorette Lozenges Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicorette Lozenges market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicorette Lozenges and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicorette Lozenges.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nicorette Lozenges manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nicorette Lozenges in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2 mg/piece Of Gum Dosage
- 4 mg/piece Of Gum Dosage
Applications
- Individual Smokers
- Withdrawal Clinics
- Medical Practice
- Others
Companies covered
- Alchem International
- Cambrex Corporation
- Dr. Reddy's Laboratories
- Fertin Pharma
- Perrigo Company
- Pharmacia
- Revolymer
- Reynolds American
- GlaxoSmithKline
- Novartis
- Johnson & Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nicorette Lozenges Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nicorette Lozenges Sales Estimates and Forecasts (2021-2032)
- 1.3 Nicorette Lozenges Market by Type
- 1.3.1 2 mg/piece Of Gum Dosage
- 1.3.2 4 mg/piece Of Gum Dosage
- 1.4 Global Nicorette Lozenges Market Size by Type
- 1.4.1 Global Nicorette Lozenges Market Size Overview by Type (2021-2032)
- 1.4.2 Global Nicorette Lozenges Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Nicorette Lozenges Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Nicorette Lozenges Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Nicorette Lozenges Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Nicorette Lozenges Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Nicorette Lozenges Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Nicorette Lozenges Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Nicorette Lozenges Industry Trends
- 2.2 Nicorette Lozenges Industry Drivers
- 2.3 Nicorette Lozenges Industry Opportunities and Challenges
- 2.4 Nicorette Lozenges Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Nicorette Lozenges Revenue (2021-2026)
- 3.2 Global Top Players by Nicorette Lozenges Sales (2021-2026)
- 3.3 Global Top Players by Nicorette Lozenges Price (2021-2026)
- 3.4 Global Nicorette Lozenges Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nicorette Lozenges Major Company Production Sites & Headquarters
- 3.6 Global Nicorette Lozenges Company, Product Type & Application
- 3.7 Global Nicorette Lozenges Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nicorette Lozenges Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nicorette Lozenges Players Market Share by Revenue in 2025
- 3.8.3 2025 Nicorette Lozenges Tier 1, Tier 2, and Tier 3
4 Nicorette Lozenges Regional Status and Outlook
- 4.1 Global Nicorette Lozenges Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Nicorette Lozenges Historic Market Size by Region
- 4.2.1 Global Nicorette Lozenges Sales in Volume by Region (2021-2026)
- 4.2.2 Global Nicorette Lozenges Sales in Value by Region (2021-2026)
- 4.2.3 Global Nicorette Lozenges Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Nicorette Lozenges Forecasted Market Size by Region
- 4.3.1 Global Nicorette Lozenges Sales in Volume by Region (2027-2032)
- 4.3.2 Global Nicorette Lozenges Sales in Value by Region (2027-2032)
- 4.3.3 Global Nicorette Lozenges Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nicorette Lozenges by Application
- 5.1 Nicorette Lozenges Market by Application
- 5.1.1 Individual Smokers
- 5.1.2 Withdrawal Clinics
- 5.1.3 Medical Practice
- 5.1.4 Others
- 5.2 Global Nicorette Lozenges Market Size by Application
- 5.2.1 Global Nicorette Lozenges Market Size Overview by Application (2021-2032)
- 5.2.2 Global Nicorette Lozenges Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Nicorette Lozenges Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Nicorette Lozenges Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Nicorette Lozenges Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Nicorette Lozenges Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Nicorette Lozenges Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Nicorette Lozenges Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Alchem International
- 6.1.1 Alchem International Company Information
- 6.1.2 Alchem International Business Overview
- 6.1.3 Alchem International Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Alchem International Nicorette Lozenges Product Portfolio
- 6.1.5 Alchem International Recent Developments
- 6.2 Cambrex Corporation
- 6.2.1 Cambrex Corporation Company Information
- 6.2.2 Cambrex Corporation Business Overview
- 6.2.3 Cambrex Corporation Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Cambrex Corporation Nicorette Lozenges Product Portfolio
- 6.2.5 Cambrex Corporation Recent Developments
- 6.3 Dr. Reddy's Laboratories
- 6.3.1 Dr. Reddy's Laboratories Company Information
- 6.3.2 Dr. Reddy's Laboratories Business Overview
- 6.3.3 Dr. Reddy's Laboratories Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Dr. Reddy's Laboratories Nicorette Lozenges Product Portfolio
- 6.3.5 Dr. Reddy's Laboratories Recent Developments
- 6.4 Fertin Pharma
- 6.4.1 Fertin Pharma Company Information
- 6.4.2 Fertin Pharma Business Overview
- 6.4.3 Fertin Pharma Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Fertin Pharma Nicorette Lozenges Product Portfolio
- 6.4.5 Fertin Pharma Recent Developments
- 6.5 Perrigo Company
- 6.5.1 Perrigo Company Company Information
- 6.5.2 Perrigo Company Business Overview
- 6.5.3 Perrigo Company Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Perrigo Company Nicorette Lozenges Product Portfolio
- 6.5.5 Perrigo Company Recent Developments
- 6.6 Pharmacia
- 6.6.1 Pharmacia Company Information
- 6.6.2 Pharmacia Business Overview
- 6.6.3 Pharmacia Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pharmacia Nicorette Lozenges Product Portfolio
- 6.6.5 Pharmacia Recent Developments
- 6.7 Revolymer
- 6.7.1 Revolymer Company Information
- 6.7.2 Revolymer Business Overview
- 6.7.3 Revolymer Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Revolymer Nicorette Lozenges Product Portfolio
- 6.7.5 Revolymer Recent Developments
- 6.8 Reynolds American
- 6.8.1 Reynolds American Company Information
- 6.8.2 Reynolds American Business Overview
- 6.8.3 Reynolds American Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Reynolds American Nicorette Lozenges Product Portfolio
- 6.8.5 Reynolds American Recent Developments
- 6.9 GlaxoSmithKline
- 6.9.1 GlaxoSmithKline Company Information
- 6.9.2 GlaxoSmithKline Business Overview
- 6.9.3 GlaxoSmithKline Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 GlaxoSmithKline Nicorette Lozenges Product Portfolio
- 6.9.5 GlaxoSmithKline Recent Developments
- 6.10 Novartis
- 6.10.1 Novartis Company Information
- 6.10.2 Novartis Business Overview
- 6.10.3 Novartis Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Novartis Nicorette Lozenges Product Portfolio
- 6.10.5 Novartis Recent Developments
- 6.11 Johnson & Johnson
- 6.11.1 Johnson & Johnson Company Information
- 6.11.2 Johnson & Johnson Business Overview
- 6.11.3 Johnson & Johnson Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Johnson & Johnson Nicorette Lozenges Product Portfolio
- 6.11.5 Johnson & Johnson Recent Developments
7 North America by Country
- 7.1 North America Nicorette Lozenges Sales by Country
- 7.1.1 North America Nicorette Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Nicorette Lozenges Sales by Country (2021-2026)
- 7.1.3 North America Nicorette Lozenges Sales Forecast by Country (2027-2032)
- 7.2 North America Nicorette Lozenges Market Size by Country
- 7.2.1 North America Nicorette Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Nicorette Lozenges Market Size by Country (2021-2026)
- 7.2.3 North America Nicorette Lozenges Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Nicorette Lozenges Sales by Country
- 8.1.1 Europe Nicorette Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Nicorette Lozenges Sales by Country (2021-2026)
- 8.1.3 Europe Nicorette Lozenges Sales Forecast by Country (2027-2032)
- 8.2 Europe Nicorette Lozenges Market Size by Country
- 8.2.1 Europe Nicorette Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Nicorette Lozenges Market Size by Country (2021-2026)
- 8.2.3 Europe Nicorette Lozenges Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Nicorette Lozenges Sales by Country
- 9.1.1 Asia-Pacific Nicorette Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Nicorette Lozenges Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Nicorette Lozenges Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Nicorette Lozenges Market Size by Country
- 9.2.1 Asia-Pacific Nicorette Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Nicorette Lozenges Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Nicorette Lozenges Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Nicorette Lozenges Sales by Country
- 10.1.1 South America Nicorette Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Nicorette Lozenges Sales by Country (2021-2026)
- 10.1.3 South America Nicorette Lozenges Sales Forecast by Country (2027-2032)
- 10.2 South America Nicorette Lozenges Market Size by Country
- 10.2.1 South America Nicorette Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Nicorette Lozenges Market Size by Country (2021-2026)
- 10.2.3 South America Nicorette Lozenges Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Nicorette Lozenges Sales by Country
- 11.1.1 Middle East and Africa Nicorette Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Nicorette Lozenges Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Nicorette Lozenges Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Nicorette Lozenges Market Size by Country
- 11.2.1 Middle East and Africa Nicorette Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Nicorette Lozenges Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Nicorette Lozenges Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Nicorette Lozenges Value Chain Analysis
- 12.1.1 Nicorette Lozenges Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Nicorette Lozenges Production Mode & Process
- 12.2 Nicorette Lozenges Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Nicorette Lozenges Distributors
- 12.2.3 Nicorette Lozenges Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst